Government SI Register · VA · High impact

Velacur

The Department of Veterans Affairs lists "Velacur" in the 2025 federal inventory as a high impact SI use case at the deployed stage, in VHA: Veterans Health Administration. In the agency's words, the problem it is meant to solve: "Velacur is a portable device intended to measure the stiffness and attenuation of the liver in a non-invasive way, via measurement of liver tissue shear modulus and ultrasound attenuation. This is done by measuring the wavelength or wave speed of mechanically created shear aves within the organ of the patient. Attenuation is measured directly via the loss in power of the ultrasound beam. The device is designed to be ..." Every field below is quoted as filed.

ID VA-24-4279Stage DeployedSource row 3475

The record, as filed

Every field the agency reported

Bureau or component
VHA: Veterans Health Administration
Stage
Deployed
High impact status
High-impact
Topic area
Health and Medical
Technology type
Classical ML
Problem it is meant to solve
Velacur is a portable device intended to measure the stiffness and attenuation of the liver in a non-invasive way, via measurement of liver tissue shear modulus and ultrasound attenuation. This is done by measuring the wavelength or wave speed of mechanically created shear aves within the organ of the patient. Attenuation is measured directly via the loss in power of the ultrasound beam. The device is designed to be used at the point of care, in clinics and hospitals. The device is used by a medical professional, an employee of the clinic/hospital. The activation unit is placed under the patient, while lying supine on an exam bed. The activation unit vibrates at frequencies of 40, 50, and 60 Hz, causing shear waves within the liver of the patient. The ultrasound transducer is placed on the patient’s skin, over the intercostal space, and is used to take volumetric scans of the liver while shear waves are occurring. The device includes two algorithms designed to help users detect good quality shear waves and identify liver tissue. From the scan data, the device calculates tissue stiffness and attenuation. Minor hardware and software changes were made to the device. The organ guide (cleared in K223287) was also extended to add more optional overlays on top of the liver overlay to help with optimizing the scan and training users to obtain adequate images. The significant change is the addition of a new output measure for Velacur, an ultrasound derived fat fraction (VDFF).
Expected benefits
Support liver stiffness measurements.
What the system outputs
The Velacur Determined Fat Fraction combines ultrasound attenuation and backscatter coefficient measurements. The device is indicated to determine liver tissue stiffness, attenuation, and Velacur Determined Fat Fraction in a non-invasive way. VDFF is not intended to be used in pediatric patients. This device's outputs are meant to be used in conjunction with other clinical indicators in order to aid in clinical management of patients with liver diseases, including hepatic steatosis. The device is intended to be used in a clinical setting and by trained medical professionals.
How it was built or bought
Vendor Purchased
Custom-developed code
No

Left blank in the record: Justification given, Operational or pilot start, Vendors, Authorization to Operate, System name, Data used to train, tune or evaluate, Federal Data Catalog link, Uses personally identifiable information, Privacy Impact Assessment, Demographic features used, Public source code, Pre-deployment testing, Impact assessment completed, Potential impacts identified, Independent review, Ongoing monitoring, Operator training, Fail-safe, Appeal process, Consultation with users and the public. Point of contact details are in the source file.

Source

Source: row 3475 of 2025_individually_reported_AI_use_cases.csv in OMB's 2025 Federal Agency AI Use Case Inventory repository (summary as of April 13, 2026), read Nov 17, 2026. File SHA-256 a62721202ca4b110

Life areas: Health and medicine, Veterans.

Records, not ratings. Every entry is what an agency reported to OMB, quoted as filed. The register does not test, rate or vouch for any system, and a record does not prove how a system is used day to day.